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Introduction
Listeria monocytogenes is a Gram-positive, rod-
shaped and facultative anaerobic bacterium. It is mo-
tile via flagella at room temperature and usually not at 
37°C, but can move within eukaryotic cells by polym-
erization of actin filaments. Listeria monocytogenes 
is a facultative intracellular bacterium that can grow 
and reproduce inside the host’s cells and is one of the 
most virulent food-borne pathogens [1]. Listeriosis is 
the leading cause of death among food-borne bacteri-
al  pathogens,  with  mortality  rates  surpassing  even 
Salmonella spp. and Clostridium botulinum [2].
Listeria monocytogenes is the common cause 
of  the  central  nervous  system  (CNS)  infections 
and bacteremia in immunicompromised and eld-
erly patients, as well as severe infections in pregnant 
women and their newborns. It can also cause gas-
troenteritis in healthy people who have ingested a 
large inoculum of the organism [3]. 
Few reports of Listeria monocytogenes infec-
tions are available from Serbia [4, 5] and hereby, a 
Corresponding Author: Doc. dr Ivana B Ćirković, Medicinski fakultet, Institut za mikrobiologiju i imunologiju, 
11000 Beograd, Dr Subotića 5, E-mail: cirkoviciv@yahoo.com
Summary
Introduction. Listeria monocytogenes is one of the most com-
mon causes of bacterial central nervous system infections in 
adults.  It  often  affects  immunicompromised  and  elderly  pa-
tients. Even with appropriate antimicrobial treatment, mortality 
due to Listeria monocytogenes meningoencephalitis is among 
the highest of all causes of bacterial central nervous system in-
fections.  Case  report.  We  presented  a  previously  healthy, 
79-year-old farmer with typical clinical features of meningoen-
cephalitis. The initial treatment with vancomycin and mero-
penem did not produce any clinical effect. On day six, Listeria 
monocytogenes was isolated from the cerebrospinal fluid and 
blood culture and identified by using conventional and auto-
mated microbiology methods. Antimicrobial susceptibility test-
ing was performed by E test method. After bacterial isolation 
and  identification,  the  administration  of  ampicillin  and  gen-
tamicin was followed by the complete recovery of our patient. 
Conclusion. This case is presented to emphasize the negative 
outcome of empirical treatment when Listeria monocytogenes is 
not taken into consideration. Furthermore, the administration of 
ampicillin and gentamicin combination for treatment should be 
considered as the best therapeutic option in Listeria monocy-
togenes meningoencephalitis.
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Sažetak
Uvod. Listeria monocytogenes jedna je od najčešćih uzročni-
ka bakterijskih infekcija centralnog nervnog sistema kod odra-
slih. Obično pogađa imunokompromitovane osobe ili pacijente 
u odmaklom životnom dobu. Čak i sa odgovarajućom antibiot-
skom terapijom, smrtnost od meningoencefalitisa koji izaziva 
Listeria  monocytogenes  je  jedna  od  najviših  među  akutnim 
bakterijskim infekcijama centralnog nervnog sistema. Prikaz 
slučaja. U radu je prikazan poljoprivrednik star 79 godina, 
prethodno zdrav, sa tipičnom kliničkom slikom meningoence-
falitisa.  Terapija  započeta  vankomicinom  i  meropenemom 
nije dala kliničko poboljšanje. Šestog dana od prijema, Liste-
ria  monocytogenes  je  izolovana  iz  likvora  i  hemokulture  i 
identifikovana korišćenjem konvencionalih i automatizovanih 
mikrobioloških  metoda.  Osetljivost  na  antimikrobne  lekove 
ispitana je E-testom. Primena ampicilina i gentamicina, mada 
odložena, dovela je do potpunog oporavka bolesnika. Zaklju-
čak. Ovaj slučaj je predstavljen da bi se naglasio negativan is-
hod  empirijskog  lečenja  bakterijskog  meningoencefalitisa 
kada  se  ne  sumnja  na  Listeria  monocytogenes.  Pored  toga, 
kombinaciju ampicilina i gentamicina treba smatrati najbo-
ljim terapijskim izborom kod meningoencefalitisa izazvanih 
Listeria monocytogenes.
Ključne  reči:  Meningoencefalitis;  Listeria  monocytogenes; 
Meningitis,  Listerija;  Bakterijske  infekcije  centralnog  ner-
vnog sistema; Stari ljudi; Muško; Dijagnoza; Antibiotici408 Ćirković BI, et al. Listeria monocytogenes meningoencephalitis
case of listerial meningoencephalitis from general 
hospital in Sombor is presented.
Case Report
A  79-year-old  male  farmer,  previously  healthy 
with  a  3-day  history  of  severe  headache,  nausea, 
vomiting and fever was admitted to the Department. 
On examination, he was febrile (38.9ºC), adynamic, 
dehydrated, with arterial blood pressure of 25/13 kPa, 
heart rate 100/minute, ventilation 25/minute. There 
were  neck  stiffness  and  positive  Kernig’s  and 
Brudzinski’s signs. Other results of physical check-up 
were normal. Leukocyte count was 16.100/mm3 (89% 
neutrophils),  platelet  count,  141.000/mm3;  erythro-
cyte sedimentation rate 28 mm/hour; and C reactive 
protein  15  mg/dL.  The  values  of  aspartate  ami-
notransferase (80 U/L), alanine aminotransferase (53 
U/L), lactate dehydrogenase (866 U/L), urea (56 mg/
dL), creatine (1.1 mg/dL) were within normal ranges. 
On admission, the cerebrospinal fluid (CSF) was ob-
tained from the patient and the analysis of slightly 
turbid  CSF  showed  pleocytosis  (white  blood  cell 
(WBC)  134/mm3,  58%  neutrophils  and  42  lym-
phocytes), elevated concentrations of proteins (1.70 
g/L)  and  decreased  glucose  concentration  (2.3 
mmol/L; simultaneous serum glucose 5.3 mmol/L). 
The patient was first treated with meropenem (2 g IV, 
q8 h) and vancomycin (1 g IV, q12 h). On day 4 after 
admission,  the  patient  was  still  febrile.  Meningeal 
syndrome was still present, and computed tomogra-
phy (CT) scan showed cerebral edema and evidence 
of recent infarction. 
On admission, blood culture, urine culture and 
CSF were taken for culturing. Blood culture and 
CSF were positive, while urine culture was sterile. 
Gram staining of the CSF and blood culture showed 
Gram-positive,  short,  non-sporing  bacilli  with 
diptheroid-like arrangement (Figure 1). For plating, 
Columbia agar (Torlak, Serbia) with 5% sheep blood 
and MacConkey agar (Torlak, Serbia) were used. No 
growth was seen on MacConkey agar, but large num-
bers of beta-haemolytic grey colonies were found on 
sheep blood agar. These colonies were identified as 
Listeria monocytogenes by using conventional micro-
biology methods and by Vitek2 System (bioMérieux, 
France) and confirmed by MALDI-TOF MS (Bruker 
Daltonics  Inc,  USA).  The  isolate  was  sensitive  to 
ampicillin (minimum inhibitory concentration (MIC) 
≤  0.125  µg/mL),  trimethoprim-sulfamethoxazole 
(MIC  ≤  0.125  µg/mL),  chloramphenicol  (MIC  ≤ 
0.125 µg/mL), gentamicin (MIC ≤ 0.064 µg/mL) and 
vancomycin (MIC ≤ 0.73 µg/mL). 
After Listeria monocytogenes isolation on day 6, 
the therapy with ampicillin (2 g IV, q4 h) and gen-
tamicin (120 mg IV) was administered. The day after, 
the patient was afebrile and the symptoms of menin-
geal syndrome started to disappear. A week after the 
treatment with ampicillin and gentamicin had begun, 
CSF analysis showed 40 WBC per mm3 (15.5% neu-
trophils and 84.5% lymphocytes), proteins of 0.35 g/L 
and glucose of 3.4 mmol/L (glycemia 5.4 mmol/L). 
The control CT scan was normal. After 21 days of 
treatment with ampicillin and gentamicin, the patient 
fully recuperated and was discharged from hospital.
Discussion
Bacterial meningoencephalitis is one of the most 
severe conditions in medicine, with the mortality rate 
going up to 30% [6]. A prerequisite for the favorable 
outcome of this disease is early administration of ad-
equate antimicrobial therapy, which usually indicates 
an  empirical  treatment.  Recommended  primary 
treatments  for  community-associated  bacterial 
meningoencephalitis in adults include third genera-
tion cephalosporins and vancomycin, with the addi-
tion of ampicillin or amoxicillin in the circumstances 
implying possible Listeria monocytogenes cause of 
the infection, e.g. older age or diseases with insuffi-
cient  cellular  immunity  [7,  8].  Listeria  mono-
cytogenes is one of the most common causes of acute 
bacterial CNS infections, after Streptococcus pneu-
moniae and Neisseria meningitides, and the frequen-
cy rate is 4-12% in a number of ountries in the north-
ern hemisphere [9–11].
In accordance with the first prospective study of 
community-associated Listeria monocytogenes men-
ingitis in adults, immunodeficiency or older age were 
characteristic for all patients [12]. Even with appro-
priate antimicrobial treatment, mortality due to Liste-
ria  monocytogenes  meningoencephalitis  is  among 
the highest of all causes of bacterial CNS infections 
[13]. This patient was an old man, with insignificant 
medical history, and with no obvious reason for im-
munodeficiency except his old age. Predictably, there 
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Figure 1. Direct Gram stained smear (blood culture) 
(1000x)
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were no epidemiologic clues implying Listeria mono-
cytogenes infection, which is mostly sporadic and 
food-borne by various types of food [1].
The  treatment  of  our  patient  was  commenced 
with meropenem and vancomycin (with proven inef-
fectivity in vivo against listeriosis) [4, 14] which is a 
common de-escalation therapy used in the hospital. 
Listeria monocytogenes harbors five penicillin-bind-
ing proteins (PBPs), and previous investigation has 
shown that PBP3 is a target for beta-lactam antibiot-
ics in this bacterium [14]. However, cephalosporins 
have low binding capacity for PBP3 in Listeria mono-
cytogenes, even though they are proven inhibitors of 
other PBPs, and they are not the drug of choice for 
listeriosis. It has also been shown in earlier studies on 
imipenem-resistant  Listeria  monocytogenes  strains 
that mutation of gene coding PBP3 is responsible for 
decreased susceptibility of the strains to the carbap-
enems [4, 14]. In addition, Stepanovic et al. reported 
meropenem  therapy  failure  in  Listeria  monocy-
togenes infection which was explained in the same 
way as in the previous study, i.e. mutation of PBP3 
gene [4]. This is a possible reason for the lack of suc-
cess  in  treatment  with  meropenem  in  our  patient. 
Ampicillin or amoxicillin is the most active antibac-
terial agents in treatment of Listeria monocytogenes 
meningitis and meningoencephalitis [15]. Moreover, 
the  results  from  in  vitro  studies  showed  that 
aminoglycosides, chloramphenicol, tetracycline and 
trimethoprim-sulfamethoxazole are also effective in 
Listeria monocytogenes infections [16]. Regrettably, 
most antibacterial agents are not bactericidal or have 
low intracellular concentration capacity [1, 15, 17]. 
The clinical practice shows that the combination of 
ampicillin or amoxicillin and gentamicin is still the 
best option [15] and it is precisely these two antibiot-
ics that are used to treat our patients.
Conclusion
Listeria monocytogenes is one of the most com-
mon causes of bacterial central nervous system infec-
tions in immunocompromised or elderly patients. Li-
steriosis  still  presents  a  diagnostic  and  therapeutic 
challenge. This case is presented to emphasize the ne-
gative outcome of empirical treatment when Listeria 
monocytogenes is not taken into consideration. Furt-
hermore,  the  administration  of  the  ampicillin  and 
gentamicin combination for treatment should be re-
garded as the best therapeutic option in Listeria mo-
nocytogenes meningoencephalitis.
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